E Cenarruzabeitia

Author PubWeight™ 10.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Are mast cells involved in hypertensive heart disease? J Hypertens 1995 0.93
2 Ecstasy-induced toxicity in rat liver. Liver 2000 0.90
3 BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons. Neuroreport 2001 0.87
4 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices. Brain Res 1997 0.82
5 Involvement of neurokinins in the non-cholinergic response to activation of 5-HT3 and 5-HT4 receptors in guinea-pig ileum. Br J Pharmacol 1994 0.81
6 Highly constrained dipeptoid analogues containing a type II' beta-turn mimic as novel and selective CCK-A receptor ligands. Bioorg Med Chem Lett 1999 0.80
7 Quinapril inhibits c-Myc expression and normalizes smooth muscle cell proliferation in spontaneously hypertensive rats. Am J Hypertens 1997 0.79
8 Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex. Brain Res 1996 0.79
9 Protection by copper (II) complexes in various models of ulceration in rat. Arzneimittelforschung 1991 0.78
10 Protective effects of calcium channel blockers in carbon tetrachloride-induced liver toxicity. Life Sci 1994 0.78
11 Comparative diltiazem plasma clearance in normotensive and hypertensive rats. J Pharm Sci 1987 0.78
12 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structure-activity relationship studies on the central 1,3-dioxoperhydropyrido[1,2-c]pyrimidine scaffold. J Med Chem 2001 0.77
13 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structural modifications at the tryptophan domain. J Med Chem 1999 0.77
14 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes. Liver 1999 0.77
15 On the nature of the 5-HT receptor subtype inhibiting acetylcholine release in the guinea-pig ileum. Br J Pharmacol 1994 0.77
16 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-position. J Med Chem 2001 0.77
17 Hepatotoxicity of ethanol: protective effect of calcium channel blockers in isolated hepatocytes. Liver 1997 0.76
18 Kinetics of pharmacological effect of diltiazem in spontaneous hypertensive rats. Methods Find Exp Clin Pharmacol 1987 0.75
19 Pharmacological characterization of the vasodilator effect of DF-100, a new pyridazino[4,5-b]indole, in vascular smooth muscle. J Cardiovasc Pharmacol 1993 0.75
20 New pyridazino[4,5-b]indole derivatives with inodilator and antiaggregatory activities. Arzneimittelforschung 1993 0.75
21 New 4-amino-7,8-dimethoxy-5H-pyrimido[5,4-b]indole derivatives: synthesis and studies as inhibitors of phosphodiesterases. Arch Pharm (Weinheim) 1993 0.75
22 On the mechanism of the anti-inflammatory activity of some copper (II) complexes. Arzneimittelforschung 1990 0.75
23 A novel class of cardiotonic agents: synthesis and biological evaluation of pyridazino[4,5-b]indoles with cyclic AMP phosphodiesterases inhibiting properties. J Pharm Sci 1993 0.75
24 3,4-methylenedioxymethamphetamine ("Ecstasy") stimulates the expression of alpha1(I) procollagen mRNA in hepatic stellate cells. Biochem Biophys Res Commun 1999 0.75
25 Anti-inflammatory activity of some copper(II) complexes. Arzneimittelforschung 1990 0.75
26 Possible mechanism of the gastroprotective activity elicited by some copper(II) complexes. Arzneimittelforschung 1991 0.75
27 Angiotensin converting enzyme inhibition prevents polyploidization of cardiomyocytes in spontaneously hypertensive rats with left ventricular hypertrophy. J Pathol 1995 0.75
28 Antihypertensive and vasodilator effect of A-80b, a new pyridazino indole derivative. Eur J Pharmacol 1992 0.75
29 Inotropic and chronotropic effects of 4-(4'-n-butylaniline)-7,8- dimethoxy-5H-pyrimido[5,4-b]indole in guinea-pig atria. J Pharm Pharmacol 1995 0.75
30 [Preliminary pharmacological studies of a new anti-inflammatory agent: 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate]. Boll Chim Farm 1982 0.75
31 Pharmacological study of the new nonsteroidal antiinflammatory agent 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate. Arzneimittelforschung 1988 0.75
32 Potential anti-diabetic applications of a new molecule with affinity for beta 3-adrenoceptors. Life Sci 1996 0.75
33 2-Oxopyrrolidines and 6-oxoperhydropyrrolo[1,2-a]pyrazines as templates in the search for nonpeptide cholecystokinin ligands. Chem Pharm Bull (Tokyo) 1998 0.75
34 beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists. J Med Chem 2000 0.75
35 On the mechanism of the pharmacological activity of the new nonsteroidal antiinflammatory agent 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate. Arzneimittelforschung 1989 0.75
36 Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 1995 0.75
37 Pharmacological activity of Prunus spinosa on isolated tissue preparations. Planta Med 1986 0.75
38 Pharmacological study of IQM-97,423, a potent and selective CCK1 receptor antagonist with protective effect in experimental acute pancreatitis. Pharmacology 2004 0.75